These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37300548)

  • 1. Suicide with oral midazolam: Postmortem toxicological investigations using Ostro® Plate and ultra-high performance liquid chromatography coupled to tandem mass spectrometry.
    Boudin C; Eysseric-Guérin H; Paysant F; Revet M; Stanke-Labesque F; Scolan V; Willeman T
    J Anal Toxicol; 2023 Jul; 47(6):535-540. PubMed ID: 37300548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry.
    Link B; Haschke M; Wenk M; Krähenbühl S
    Rapid Commun Mass Spectrom; 2007; 21(9):1531-40. PubMed ID: 17410605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a method using supported liquid extraction for the simultaneous determination of midazolam and 1'-hydroxy-midazolam in human plasma by liquid chromatography with tandem mass spectrometry detection.
    Svanström C; Hansson GP; Svensson LD; Sennbro CJ
    J Pharm Biomed Anal; 2012 Jan; 58():71-7. PubMed ID: 21993197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and simultaneous measurement of midazolam, 1'-hydroxymidazolam and digoxin by liquid chromatography/tandem mass spectrometry: application to an in vivo study to simultaneously measure P-glycoprotein and cytochrome P450 3A activity.
    Xue X; Huang M; Xiao H; Qin X; Huang L; Zhong G; Bi H
    J Pharm Biomed Anal; 2011 Apr; 55(1):187-93. PubMed ID: 21316177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Dexmedetomidine on the Pharmacokinetics of Dezocine, Midazolam and Its Metabolite 1-Hydroxymidazolam in Beagles by UPLC-MS/MS.
    Zhou W; Li SL; Zhao T; Li L; Xing WB; Qiu XJ; Zhang W
    Drug Des Devel Ther; 2020; 14():2595-2605. PubMed ID: 32753841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of midazolam and its major metabolite 1'-hydroxymidazolam by high-performance liquid chromatography-electrospray mass spectrometry in plasma from children.
    Muchohi SN; Ward SA; Preston L; Newton CR; Edwards G; Kokwaro GO
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(1):1-7. PubMed ID: 15914101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimization of midazolam dosage and pharmacokinetics of CYP3A probe substrate in rats].
    Qin XL; Duan WH; Xue XP; Chen X; Huang M; Bi HC
    Yao Xue Xue Bao; 2016 May; 51(5):834-8. PubMed ID: 29878735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UPLC-MS/MS analysis of the Michaelis-Menten kinetics of CYP3A-mediated midazolam 1'- and 4-hydroxylation in rat brain microsomes.
    Venkatapura Chandrashekar D; DuBois B; Mehvar R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1180():122892. PubMed ID: 34388602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation by gas chromatography of the 1- and 4-hydroxy metabolites of midazolam in human plasma.
    Arendt RM; Greenblatt DJ; Garland WA
    Pharmacology; 1984; 29(3):158-64. PubMed ID: 6483962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly sensitive LC-MS-MS assay for analysis of midazolam and its major metabolite in human plasma: applications to drug metabolism.
    Jabor VA; Coelho EB; Dos Santos NA; Bonato PS; Lanchote VL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):27-32. PubMed ID: 15993663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A developed determination of midazolam and 1'-hydroxymidazolam in plasma by liquid chromatography-mass spectrometry: application of human pharmacokinetic study for measurement of CYP3A activity.
    Shimizu M; Uno T; Tamura HO; Kanazawa H; Murakami I; Sugawara K; Tateishi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):275-81. PubMed ID: 17085083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and elimination kinetics of midazolam and metabolites after post-resuscitation care: a prospective observational study.
    Jeong W; Sunwoo J; You Y; Park JS; Min JH; In YN; Ahn HJ; Jeon SY; Hong JH; Song JH; Kang H; Nguyen MTT; Kim J; Kang C
    Sci Rep; 2024 Feb; 14(1):4574. PubMed ID: 38403792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC-MS/MS.
    Ghassabian S; Moosavi SM; Valero YG; Shekar K; Fraser JF; Smith MT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():126-33. PubMed ID: 22841553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers.
    Krupka E; Venisse N; Lafay C; Gendre D; Diquet B; Bouquet S; Perault MC
    Eur J Clin Pharmacol; 2006 Aug; 62(8):653-9. PubMed ID: 16832678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood concentrations of midazolam in status epilepticus using an appropriate condition of HPLC.
    Iwasaki T; Nonoda Y; Ishii M; Osawa M
    Pediatr Int; 2010 Aug; 52(4):513-9. PubMed ID: 20003143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated high-capacity on-line extraction and bioanalysis of dried blood spot samples using liquid chromatography/high-resolution accurate mass spectrometry.
    Oliveira RV; Henion J; Wickremsinhe ER
    Rapid Commun Mass Spectrom; 2014 Nov; 28(22):2415-26. PubMed ID: 25303470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Suboptimal 25-Hydroxyvitamin D Levels and Cholecalciferol Replacement on the Pharmacokinetics of Oral Midazolam in Control Subjects and Patients With Chronic Kidney Disease.
    Tuey SM; Prebehalla L; Roque AA; Roda G; Chonchol MB; Shah N; Wempe MF; Hu Y; Hogan SL; Nolin TD; Joy MS
    J Clin Pharmacol; 2022 Dec; 62(12):1528-1538. PubMed ID: 35678297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of drug screening in forensic autopsy: retrospective investigation of routine toxicological findings.
    Tominaga M; Michiue T; Inamori-Kawamoto O; Hishmat AM; Oritani S; Takama M; Ishikawa T; Maeda H
    Leg Med (Tokyo); 2015 May; 17(3):172-6. PubMed ID: 25637163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) models.
    Vossen M; Sevestre M; Niederalt C; Jang IJ; Willmann S; Edginton AN
    Theor Biol Med Model; 2007 Mar; 4():13. PubMed ID: 17386084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-mechanistic autoinduction model of midazolam in critically ill patients: population pharmacokinetic analysis.
    Aoyama T; Hirata K; Yamamoto Y; Yokota H; Hayashi H; Aoyama Y; Matsumoto Y
    J Clin Pharm Ther; 2016 Aug; 41(4):392-8. PubMed ID: 27178380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.